Abstract

Methotrexate 25-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2013 - Volume 17, Number 5

Page(s): 421

Download in electronic PDF format for $75
  • Methotrexate 25-mg/mL Injection Page 1

Abstract

A formulation for preparing Methotrexate 25-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • methotrexate
  • formulation
  • compounded sterile preparations
  • cancer
  • psoriasis
  • rheumatoid arthritis
  • inflammation
  • anti-inflammatory agents

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • FORMULATIONS
  • STERILE PREPARATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2013
Pg. 421
Methotrexate 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 238
Methotrexate 2.5-mg Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 235
Methotrexate 2-mg/mL Oral Solution
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jan/Feb 2011
Pg. 68
Methotrexate 30-mg/g Topical Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Jul/Aug 2017
Pg. 301-308
Basics of Sterile Compounding: Excipients Used in Injections
Author(s): Akers Michael J
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank